Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (4): 40-45    DOI:
    
Preparation and Preliminary Characterization of Monoclonal Antibodies against E2 Protein of Bovine Viral Diarrhea Virus
WANG Shu1,2, ZHU Yuan-mao2, CAI Hong2, MA Lei2, SHI Hong-fei2, LÜ Chuang2, DONG Xiu-mei2, GAO Yu-ran2, XUE Fei2
1. College of Veterinary Medicine, Northeast Agricultural University, Harbin 150001, China;
2. Division of Livestock Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150001, China
Download: HTML   PDF(763KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  To prepare monoclonal antibody (MAb) against glycoprotein E2 of bovine viral diarrhea virus (BVDV), BALB/c mice were immunized with purified recombinant E2(rE2) expressed in E.coli and two hybridomas secreting MAb were screened from fusing the SP2/0 cells with the spleen cells of the immunized BALB/c mice by indirect ELISA coated with BVDV.The titers of MAb 4E3 and 1G11 in ascites were 6.21×106,6.83×105, 6.83×105, and 7.5×104 as detected by rE2 and BVDV, respectively. The MAbs secreted by hybridomas 4E3 and 1G11 had highly reactivity and specificity in indirect ELISA, Western blotting, IFA and identified as IgM with a light chain of κ by indirect ELISA.The specific tests indicated that the MAbs 4E3 and 1G11 had no reaction with bovine infectious rhinotracheitis virus,bovine parainfluenza virus type 3 and bovine adenovirus type 3.Meanwhile the MAb 4E3 had no reaction with classical swine fever virus(CSFV)and the MAb 1G11 had reaction with CSFV.Therefore the MAbs 4E3 and 1G11 might be used for differentiating BVDV and CSFV.On the other hand, the MAbs 4E3 and 1G11 could be used for establish diagnosis method for BVDV.

Key wordsBovine viral diarrhea virus      E2 protein      Monoclonal antibody      IgM     
Received: 03 December 2012      Published: 25 April 2013
ZTFLH:  Q819  
Cite this article:

WANG Shu, ZHU Yuan-mao, CAI Hong, MA Lei, SHI Hong-fei, LÜ Chuang, DONG Xiu-mei, GAO Yu-ran, XUE Fei. Preparation and Preliminary Characterization of Monoclonal Antibodies against E2 Protein of Bovine Viral Diarrhea Virus. China Biotechnology, 2013, 33(4): 40-45.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I4/40

[1] 殷震,刘景华. 动物病毒学. 第2版.北京:科学出版社,1997.631-645. Yin Z,Liu J H. Animal Virology.2nd ed. Beijing:Science Press,1997.631-645.
[2] 范进江,薄新文, 钟发刚. 牛病毒性腹泻病毒基因组结构与蛋白功能研究进展. 动物医学进展,2008,29(5):68-72. Fan J J,Bo X W, Zhong F G.Advance in genomic structure and protein function of bovine viral diarrhea virus.Progress in Veterinary Medicine,2008,2(5):68-78.
[3] Weiland E, Stark R,Haas B,et al. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disultide-linked heterodimer. Virology, 1990, 64: 3563-3569.
[4] 李娇,薛飞,朱远茂,等.牛病毒性腹泻病毒E2蛋白的截短表达与鉴定.中国预防兽医学报,2008,30(3): 200-204. Li J, Xue F, Zhu Y M, et al. Expression and characterization of truncate E2 protein of bovine viral diarrhea virus in Escherichia coli. Chinese Journal of Preventive Vererinary Medicine, 2008, 30(3):200-204.
[5] 高欲燃,朱远茂,康健,等. 牛病毒性腹泻病毒 E2 蛋白的多克隆抗体制备及鉴定. 中国预防兽医学报,2011,33(3):227-231. Gao Y R, Zhu Y M, Kang J, et al. Preparation and characterization of antisera against recombinant E2 protein of bovine viral diarrhea virus.Chinese Journal of Preventive Vererinary Medicine, 2011,33(3):227-231.
[6] Naundor S, Preithner S, Mayer P, et al. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment. Int J Cancer, 2002, 100:101-110.
[7] SamBrook J, Russell D W. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor, Cold Spring Harber Laboratory Press, 2002.
[8] 王新平,任文陟,朱维正,等. 双抗体夹心ELISA检测牛病毒性腹泻病毒的研究.中国兽医学报,1995, 15(3):246-249. Wang X P, Ren W Z, Zhu W Z, et al. Detection of bovine viral diarrhen virus with sandwich ELISA.China Journal of Veterinary Scinece, 115, 15(3):246-249.
[9] Marzocca M P, Seki C, Giambiagi S M, et al. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: A candidate antigen for a BVDV ELISA. J Virol Methods, 2007, 144: 49-56.
[10] Thomas C, Young N J, Heaney J, et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine, 2009, 27: 2387-2393.
[11] 沈敏,王新华,周鹏飞,等. BVD-MDV 细胞毒的快速粗提. 中国畜禽传染病,1997, 4(95):58-59. Shen M,Wang X H, Zhou P F, et al. Rapid extraction of cytotoxic BVDV/MDV.Chinese Joural of Animal and Poultry Infectious Diseases, 1997, 4(95):58-59.
[1] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[2] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[3] JIANG Yi-fan,JIA Yu,Wang Long,WANG Zhi-ming. The Glycosylation Design and Control of Monoclonal Antibody by Cell Culture[J]. China Biotechnology, 2019, 39(8): 95-103.
[4] LIU Guo-fang,LIU Xiao-zhi,GAO Jian,WANG Zhi-ming. Effects of Host Cell Residual Proteins on the Quality and Their Quality Control of Monoclonal Antibody[J]. China Biotechnology, 2019, 39(10): 105-110.
[5] Jian-wei REN,Jun LI,Shang-ze LI. Human CT55 Protein Prokaryotic Expression and Its Production of Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 1-8.
[6] Kai-yun MAO,Yue-lei FAN,Heng-zhe WANG,Da-ming CHEN. Market Competition Pattern of Global PD-1/PD-L1 Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 103-115.
[7] Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO,Gui-lin LI. Advance in Large-Scale Culture of Hybridoma Cells in Vitro[J]. China Biotechnology, 2018, 38(10): 82-89.
[8] WANG Yun-long, ZHAO Er-xia, LI Yu-lin. Expression, Purification and Identification of Thymidine Kinase 1 Recombinant Protein[J]. China Biotechnology, 2017, 37(9): 15-22.
[9] MENG Ying-ying, YAO Chang-hong, LIU Jiao, SHEN Pei-li, XUE Song, YANG Qing. Review and Evaluation of Microalgal Components Determination Methods[J]. China Biotechnology, 2017, 37(7): 133-143.
[10] WU Meng-ling, ZHOU Jia-wang, DU Jun. Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal[J]. China Biotechnology, 2017, 37(3): 51-57.
[11] LI Min, WU Ri-wei. The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad[J]. China Biotechnology, 2017, 37(3): 106-114.
[12] HOU Bing-xiao, LIU Shan-na, WANG Bin-bin, ZHU Hong-ji, QIAO Jian-jun. Advances on Regulatory Mechanism of Heat-shock Proteins[J]. China Biotechnology, 2016, 36(9): 87-93.
[13] REN Hua-jing, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progression of Central Nervous System Disease Therapeutic Antibody Drug Application[J]. China Biotechnology, 2016, 36(9): 54-58.
[14] ZHANG Yin-chuan, LIU Meng-meng, ZHANG Ya-ting, GUI Fang, ZHANG Ai-hua, BI Lan, PAN Yong-bin. Construction and Screening of Recombinant Cell Line Expressing Fully-human mAbs against Human IgE[J]. China Biotechnology, 2015, 35(3): 66-74.
[15] WANG Lan, XIA Mao, GAO Kai. The Development and Quality Control of Antibody-Drug Conjugates[J]. China Biotechnology, 2014, 34(4): 85-94.